CvxCodes: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==CVX Codes for Vaccines== Certain States require this code to be sent in place of or in addition to the NDC number for the vaccine. {| class="wikitable sortable" border="1" s...") |
(No difference)
|
Revision as of 19:54, 3 November 2020
CVX Codes for Vaccines
Certain States require this code to be sent in place of or in addition to the NDC number for the vaccine.
| Vaccine | NDC # | CVX Code |
|---|---|---|
| Hib (PRP-T) | 49281-0547-58 | 48 |
| Tdap | 49281-0400-89 | 115 |
| Tdap | 49281-0400-58 | 115 |
| Tdap | 49281-0400-88 | 115 |
| Adenovirus types 4 and 7 | 51285-0175-02 | 143 |
| Adenovirus types 4 and 7 | 51285-0174-02 | 143 |
| Influenza, injectable,quadrivalent, preservative free, pediatric | 33332-0220-21 | 161 |
| influenza, injectable, quadrivalent | 33332-0420-11 | 158 |
| influenza, injectable, quadrivalent, preservative free | 33332-0320-02 | 150 |
| BCG | 00052-0603-01 | 19 |
| meningococcal B, OMV | 58160-0976-02 | 163 |
| anthrax | 64678-0211-05 | 24 |
| Tdap | 58160-0842-05 | 115 |
| Tdap | 58160-0842-43 | 115 |
| Tdap | 58160-0842-01 | 115 |
| DTaP, 5 pertussis antigens | 49281-0286-58 | 106 |
| dengue fever | 49281-0606-58 | 56 |
| DT (pediatric) | 49281-0225-58 | 28 |
| Hep B, adult | 58160-0821-01 | 43 |
| Hep B, adult | 58160-0821-43 | 43 |
| Hep B, adolescent or pediatric | 58160-0820-43 | 08 |
| Hep B, adult | 58160-0821-05 | 43 |
| influenza, trivalent, adjuvanted | 70461-0020-04 | 168 |
| Influenza vaccine, quadrivalent, adjuvanted | 70461-0120-04 | 205 |
| influenza, injectable, quadrivalent, preservative free | 58160-0885-41 | 150 |
| influenza, recombinant, quadrivalent,injectable, preservative free | 49281-0720-88 | 185 |
| Influenza, injectable, MDCK, quadrivalent, preservative | 70461-0420-11 | 186 |
| Influenza, injectable, MDCK, preservative free, quadrivalent | 70461-0320-04 | 171 |
| influenza, injectable, quadrivalent, preservative free | 19515-0816-41 | 150 |
| influenza, live, intranasal, quadrivalent | 66019-0307-01 | 149 |
| influenza, high-dose, quadrivalent | 49281-0120-88 | 197 |
| influenza, injectable, quadrivalent, preservative free | 49281-0420-88 | 150 |
| influenza, injectable, quadrivalent, preservative free | 49281-0420-58 | 150 |
| Influenza, injectable,quadrivalent, preservative free, pediatric | 49281-0520-00 | 161 |
| influenza, injectable, quadrivalent | 49281-0633-78 | 158 |
| influenza, Southern Hemisphere, quadrivalent, with preservative | 49281-0336-78 | 202 |
| influenza, Southern Hemisphere, preservative free | 49281-0320-88 | 201 |
| influenza, Southern Hemisphere, pediatric, preservative free | 49281-0181-00 | 200 |
| HPV, quadrivalent | 00006-4045-01 | 62 |
| HPV, quadrivalent | 00006-4109-01 | 62 |
| HPV9 | 00006-4121-01 | 165 |
| HPV9 | 00006-4119-01 | 165 |
| Hep A, ped/adol, 2 dose | 58160-0825-43 | 83 |
| Hep A, adult | 58160-0826-01 | 52 |
| Hep A, adult | 58160-0826-43 | 52 |
| Hep A, ped/adol, 2 dose | 58160-0825-01 | 83 |
| HepB-CpG | 43528-0003-01 | 189 |
| Hib (PRP-T) | 58160-0816-05 | 48 |
| Hib (PRP-T) | 58160-0816-01 | 48 |
| Rabies - IM Diploid cell culture | 49281-0246-58 | 175 |
| Rabies - IM Diploid cell culture | 49281-0248-58 | 175 |
| DTaP | 58160-0810-01 | 20 |
| DTaP | 50090-2883-09 | 20 |
| DTaP | 58160-0810-43 | 20 |
| Influenza A monovalent (H5N1), ADJUVANTED-2013 | 58160-0804-01 | 160 |
| Influenza A monovalent (H5N1), ADJUVANTED-2013 | 58160-0802-02 | 160 |
| IPV | 49281-0860-78 | 10 |
| Japanese Encephalitis IM | 62195-0051-01 | 134 |
| Japanese Encephalitis IM | 42515-0001-00 | 134 |
| Japanese Encephalitis IM | 42515-0002-01 | 134 |
| DTaP-IPV | 58160-0812-43 | 130 |
| DTaP-IPV | 58160-0812-01 | 130 |
| meningococcal MCV4P | 49281-0589-58 | 114 |
| meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate | 49281-0590-58 | 203 |
| Meningococcal MCV4O | 58160-0958-01 | 136 |
| Meningococcal MCV4O | 58160-0959-01 | 136 |
| MMR | 00006-4681-01 | 03 |
| DTaP-Hep B-IPV | 58160-0811-43 | 110 |
| Hib (PRP-OMP) | 00006-4897-01 | 49 |
| DTaP-Hib-IPV | 49281-0560-05 | 120 |
| DTaP-Hib-IPV | 49281-0561-01 | 120 |
| DTaP-Hib-IPV | 49281-0548-58 | 120 |
| DTaP-Hib-IPV | 49281-0544-58 | 120 |
| pneumococcal polysaccharide PPV23 | 00006-4943-01 | 33 |
| pneumococcal polysaccharide PPV23 | 00006-4837-01 | 33 |
| Pneumococcal conjugate PCV 13 | 00005-1971-01 | 133 |
| MMRV | 00006-4171-01 | 94 |
| DTaP-IPV | 49281-0562-58 | 130 |
| Rabies - IM fibroblast culture | 58160-0966-01 | 176 |
| Hep B, dialysis | 00006-4992-01 | 44 |
| Hep B, adolescent or pediatric | 00006-4093-01 | 08 |
| Hep B, adult | 00006-4094-01 | 43 |
| Hep B, adult | 00006-4995-01 | 43 |
| Hep B, adolescent or pediatric | 00006-4981-01 | 08 |
| rotavirus, monovalent | 58160-0851-01 | 119 |
| rotavirus, pentavalent | 00006-4047-01 | 116 |
| zoster recombinant | 58160-0828-01 | 187 |
| zoster recombinant | 58160-0828-03 | 187 |
| Yellow fever vaccine - alt | 49281-0913-01 | 183 |
| Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed | 14362-0111-03 | 09 |
| Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed | 13533-0131-00 | 09 |
| Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed | 49281-0215-58 | 113 |
| Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed | 49281-0215-88 | 113 |
| meningococcal B, recombinant | 00005-0100-01 | 162 |
| Hep A-Hep B | 58160-0815-43 | 104 |
| Hep A-Hep B | 58160-0815-41 | 104 |
| typhoid, ViCPs | 49281-0790-88 | 101 |
| typhoid, ViCPs | 49281-0790-38 | 101 |
| Hep A, adult | 00006-4841-01 | 52 |
| Hep A, ped/adol, 2 dose | 00006-4095-01 | 83 |
| Hep A, ped/adol, 2 dose | 00006-4831-01 | 83 |
| Hep A, adult | 00006-4096-01 | 52 |
| varicella | 00006-4826-01 | 21 |
| varicella | 00006-4827-01 | 21 |
| cholera, live attenuated | 70460-0002-02 | 174 |
| DTaP,IPV,Hib,HepB | 63361-0243-58 | 146 |
| typhoid, oral | 69401-0000-01 | 25 |
| typhoid, oral | 69401-0000-01 | 25 |
| yellow fever | 49281-0915-58 | 37 |
| yellow fever | 49281-0915-68 | 37 |
| zoster live | 00006-4963-01 | 121 |